Global Breast Biopsy Devices Market Segmentation, By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other) – Industry Trends and Forecast to 2031.
Breast Biopsy Devices Market Analysis
Biopsy refers to a procedure that is used for surgical removal of tissue from an organ. The procedure is done to determine the presence or extent of a disease, including inflammatory and cancerous conditions. The prevalence of chronic diseases is escalating the growth of breast biopsy devices market.
Breast Biopsy Devices Market Size
Global breast biopsy devices market size was valued at USD 2.69 billion in 2023 and is projected to reach USD 4.78 billion by 2031, with a CAGR of 7.45% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Breast Biopsy Devices Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Scion Medical Technologies LLC (US), STERYLAB S.r.l. (Italy), ARGON MEDICAL (US), Danaher (US), Cianna Medical (US), Benetec (Belgium), Cigna (US), United Medical Systems Inc. (US), Stryker (US), BD (US), Hologic Inc. (US), Devicor Medical Products Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), OncoCyte Corporation (US), Cook (US), Siemens (Germany), Medtronic (Ireland), SOMATEX Medical Technologies GmbH (Germany), Vigeosrl (Italy), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GENERAL ELECTRIC (US), Cardinal Health (US) and B. Braun Melsungen AG (Germany), among others
|
Breast Biopsy Devices Market Definition
Biopsy devices refer to the devices that are utilized for removing a piece of a sample or a tissue of cells from the body in order to analyse in the laboratory for presence of a disease. The devices are used among radiologists, interventional cardiologists and surgeons. The use of these biopsy devices varies depending on the type of organ under consideration.
Breast Biopsy Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Prevalence of Cancer
The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of breast biopsy devices market.
- Preference for Minimally Invasive Surgeries
The increase in the inclination towards minimally invasive surgeries among population owing to the quick recovery and less pain accelerate the market growth.
- Funds and Grants
The surge in investments in the form of funds and grants for biomarker research further influence the market growth.
Opportunities
Furthermore, development of fully integrated biopsy devices extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, emergence of liquid biopsy will assist in the expansion of the market.
Restraints/Challenges
On the other hand, concerns regarding the product recalls are expected to obstruct market growth. Also, risk of infections is projected to challenge the breast biopsy devices market in the forecast period of 2024-2031.
This breast biopsy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on breast biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Breast Biopsy Devices Market
Covid-19 had a positive impact on the breast biopsy devices market. The medical services such as biopsies witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the number of biopsies is expected in the post-COVID owing to the easing of restrictions.
Global Breast Biopsy Devices Market Scope
The biomarkers market is segmented on the basis of product, technique type, guidance technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Biopsy Needles
- Biopsy Tables
- Biopsy Wires
- Guidance Systems
- Others
Technique Type
- Fine Needle Aspiration Biopsy
- Core Needle Biopsy
- Biopsy Markers
- Mri-Guided Core Needle Biopsy
- Surgical Biopsy
- Wire Localization
- Sentinel Node Biopsy
Guidance Technology
- Fine Ultrasound-Guided
- Mammography-Guided Magnetic Resonance
- Ct-Guided Biopsy
- Other Image-Guided Breast Biopsy
End User
- Into Hospitals
- Ambulatory Surgical Centres
- Diagnostic Centres
- Other
Breast Biopsy Devices Market Regional Analysis
The breast biopsy devices market is analysed and market size insights and trends are provided by country, product, technique type, guidance technology and end user as referenced above.
The countries covered in the breast biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the breast biopsy devices market because of the large availability of trained medical professionals and availability of well-developed infrastructure facilities within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the surge in disposable income and rise in patient awareness toward disease screening in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The breast biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast biopsy devices market. The data is available for historic period 2010-2020.
Breast Biopsy Devices Market Share
The breast biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to breast biopsy devices market.
Breast Biopsy Devices Market Leaders Operating in the Market Are:
- Scion Medical Technologies LLC (US)
- STERYLAB S.r.l. (Italy)
- ARGON MEDICAL (US)
- Danaher (US)
- Cianna Medical (US)
- Benetec (Belgium)
- Cigna (US)
- United Medical Systems Inc. (US)
- Stryker (US)
- BD (US)
- Hologic Inc. (US)
- Devicor Medical Products Inc. (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- OncoCyte Corporation (US)
- Cook (US)
- Siemens (Germany)
- Medtronic (Ireland)
- SOMATEX Medical Technologies GmbH (Germany)
- Vigeosrl (Italy)
- Johnson & Johnson Services Inc. (US)
- Boston Scientific Corporation (US)
- Olympus Corporation (Japan)
- FUJIFILM Holdings Corporation (Japan)
- GENERAL ELECTRIC (US)
- Cardinal Health (US)
- B. Braun Melsungen AG (Germany)
Latest Development in Breast Biopsy Devices Market
- IZI Medical Products, LLC ("IZI") launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") in March’2021 for the purpose of soft tissue biopsy. Quick-Core Auto is known to be a lightweight, completely automatic biopsy equipment offering precision, reliability, and quality of IZI's Quick-Core semi-automatic biopsy system.
SKU-